399 related articles for article (PubMed ID: 32582768)
21. Subclinical cerebral abnormalities in chronic kidney disease.
Yao H; Takashima Y; Hashimoto M; Uchino A; Yuzuriha T
Contrib Nephrol; 2013; 179():24-34. PubMed ID: 23652446
[TBL] [Abstract][Full Text] [Related]
22. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
Bobot M
Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
[TBL] [Abstract][Full Text] [Related]
23. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
Levin A
Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
[TBL] [Abstract][Full Text] [Related]
24. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
[TBL] [Abstract][Full Text] [Related]
25. Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.
Dad T; Weiner DE
Semin Nephrol; 2015 Jul; 35(4):311-22. PubMed ID: 26355250
[TBL] [Abstract][Full Text] [Related]
26. Chronic kidney disease and cognitive impairment.
Pépin M; Villain C
Geriatr Psychol Neuropsychiatr Vieil; 2021 Oct; ():. PubMed ID: 34612821
[TBL] [Abstract][Full Text] [Related]
27. Covert vascular brain injury in chronic kidney disease.
Miwa K; Toyoda K
Front Neurol; 2022; 13():824503. PubMed ID: 35959397
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric Disorders in Chronic Kidney Disease.
Simões E Silva AC; Miranda AS; Rocha NP; Teixeira AL
Front Pharmacol; 2019; 10():932. PubMed ID: 31474869
[TBL] [Abstract][Full Text] [Related]
29. [Brain atrophy and cognitive impairment in patients with chronic kidney disease].
Tsuruya K
Nihon Rinsho; 2014 Apr; 72(4):708-14. PubMed ID: 24796102
[TBL] [Abstract][Full Text] [Related]
30. Cerebral Microbleeds Are Associated With Mild Cognitive Impairment in Patients With Hypertension.
Zhang J; Liu L; Sun H; Li M; Li Y; Zhao J; Li J; Liu X; Cong Y; Li F; Li Z
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858365
[TBL] [Abstract][Full Text] [Related]
31. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.
Werring DJ; Frazer DW; Coward LJ; Losseff NA; Watt H; Cipolotti L; Brown MM; Jäger HR
Brain; 2004 Oct; 127(Pt 10):2265-75. PubMed ID: 15282216
[TBL] [Abstract][Full Text] [Related]
32. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
Conen D; Rodondi N; Müller A; Beer JH; Ammann P; Moschovitis G; Auricchio A; Hayoz D; Kobza R; Shah D; Novak J; Schläpfer J; Di Valentino M; Aeschbacher S; Blum S; Meyre P; Sticherling C; Bonati LH; Ehret G; Moutzouri E; Fischer U; Monsch AU; Stippich C; Wuerfel J; Sinnecker T; Coslovsky M; Schwenkglenks M; Kühne M; Osswald S;
J Am Coll Cardiol; 2019 Mar; 73(9):989-999. PubMed ID: 30846109
[TBL] [Abstract][Full Text] [Related]
33. Association of mild kidney dysfunction with silent brain lesions in neurologically normal subjects.
Toyoda G; Bokura H; Mitaki S; Onoda K; Oguro H; Nagai A; Yamaguchi S
Cerebrovasc Dis Extra; 2015; 5(1):22-7. PubMed ID: 25873927
[TBL] [Abstract][Full Text] [Related]
34. Cerebrovascular disease.
Portegies ML; Koudstaal PJ; Ikram MA
Handb Clin Neurol; 2016; 138():239-61. PubMed ID: 27637962
[TBL] [Abstract][Full Text] [Related]
35. New aspects of cerebrovascular diseases in dialysis patients.
Naganuma T; Takemoto Y
Contrib Nephrol; 2015; 185():138-46. PubMed ID: 26023023
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Brain MRI Markers of Hemorrhagic Risk in Patients with Stroke and Atrial Fibrillation.
Karayiannis C; Soufan C; Chandra RV; Phan TG; Wong K; Singhal S; Slater LA; Ly J; Moran C; Srikanth V
Front Neurol; 2016; 7():151. PubMed ID: 27703444
[TBL] [Abstract][Full Text] [Related]
37. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
38. The Presence of Previous Cerebral Microbleeds Has a Negative Effect on Hypertensive Intracerebral Hemorrhage Recovery.
Yang K; Feng Y; Mu J; Fu N; Chen S; Fu Y
Front Aging Neurosci; 2017; 9():49. PubMed ID: 28326034
[No Abstract] [Full Text] [Related]
39. Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview.
Kulkarni N; Gukathasan N; Sartori S; Baber U
J Atr Fibrillation; 2012; 5(1):448. PubMed ID: 28496746
[TBL] [Abstract][Full Text] [Related]
40. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
